Nasdaq finally ‘warming up’ to Canadian cannabis companies with U.S. exposure. Could American growers be next?
The Nasdaq stock exchange is “warming up” to the idea of continuing to list Canadian cannabis companies even if they have ...
Nasdaq Plans More Short-Term Options on Commodity, Treasury ETFs
In the latest sign of booming interest in short-duration options, Nasdaq Inc. plans in coming weeks to seek regulatory ...
Spain's Ferrovial expects Nasdaq listing in early May
Spain's Ferrovial expects to list on Nasdaq around May 9 after concluding a regulatory review for its registration, the ...
Ferrovial Shares to Begin Trading on the Nasdaq
By Stephen Nakrosis Ferrovial SE said Friday it completed the regulatory review process for its registration statement with the U.S. Securities and ...
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, is ...
FXEmpire.com1d
Nasdaq Index, Dow Jones, S&P 500 News: Wall Street Bracing for Volatility as CPI Data Looms
The previous trading session concluded with the S&P 500 marginally down by 0.04%, the Dow Jones Industrial Average slightly lower by 0.03%, and the Nasdaq Composite marginally up by 0.03%.
The Motley Fool16d
History Says the Nasdaq Will Soar in 2024. Here's the ETF to Buy Before That Happens.
If history is a guide, the Nasdaq could climb into the double digits this year. Betting on Nasdaq stocks would help you benefit from the momentum -- but you don’t have to be a stock-picking ...
Twelve Seas Investment Company II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
Twelve Seas Investment Company II (NASDAQ): TWLV) (the “Company”) today announced that it has received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market ...
Business Wire1d
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform ...
How RTX Corp. Crushed Its Q1 Earnings Report
RTX reported $19.3 billion in Q1 2024 sales, up 12% from Q1 2023. Its earnings growth was even better, a 32% year-over-y ...